Litcius/Paper detail

Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisation

Qian Wang, Zhiteng Li, Jerren Ho, Yicheng Guo, Andre Yanchen Yeh, Hiroshi Mohri, Michael Liu, Maple Wang, Jian Yu, Jayesh Shah, Jennifer Y. Chang, Favio Herbas, Michael T. Yin, Magdalena E. Sobieszczyk, Zizhang Sheng, Lihong Liu, David D. Ho

2022The Lancet Infectious Diseases82 citationsDOIOpen Access PDF

Topics & Concepts

NeutralizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakAntibodyBiologyMedicineVirusGeneticsInfectious disease (medical specialty)OutbreakDiseasePathologySARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesMonoclonal and Polyclonal Antibodies Research
Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisation | Litcius